Skip to Content

SIGN IN

Bristol-Myers Squibb
RANK115

The biopharmaceutical company manufactures medicines for diseases including cancer, diabetes, and psychiatric disorders.

Regis Duvignau—Reuters

Lists ranking Bristol-Myers Squibb

Global 500 - 2020This year's Global 500 generated $33.3 trillion in...READ MOREview in list

Fortune 500 - 2020This year's Fortune 500 marks the 66th running of ...READ MOREview in list

Latest news for Bristol-Myers Squibb

Seniors face steep drug costs as Congress stalls on capping Medicare out-of-pockets

By

and

Kaiser Health News

December 28, 2020 10:00 AM UTC

Warren Buffett is going all in on the vaccine rally, piling into these stocks

By

Katherine Chiglinsky

and

November 17, 2020 10:55 AM UTC

Bristol Myers Squibb and Celgene got a beating in Congress on drug prices—but only Congress can fix the problem

By

October 1, 2020 10:28 PM UTC

Diversity is long overdue in the drug industry—and it’s going to take more than just hiring Black candidates

By

August 12, 2020 5:08 PM UTC

Healthcare is in the midst of a ‘paradigm shift’

By

and

July 8, 2020 10:14 AM UTC

© 2020 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell My Personal Information | Ad Choices
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.
Quotes delayed at least 15 minutes. Market data provided by Interactive Data. ETF and Mutual Fund data provided by Morningstar, Inc. Dow Jones Terms & Conditions: http://www.djindexes.com/mdsidx/html/tandc/indexestandcs.html.
S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.